Longer-term outcomes after bicuspid aortic valve repair in 142 patients
Autor: | Afsaneh Karimian-Tabrizi, Arnaud Van Linden, Thomas Walther, Mojyan Safari, Tomas Holubec, Alexandra Miskovic, Pavel Zacek, Nadejda Monsefi, Anton Moritz |
---|---|
Rok vydání: | 2021 |
Předmět: |
Pulmonary and Respiratory Medicine
Aortic valve Adult Reoperation medicine.medical_specialty Aortic root Aortic Valve Insufficiency Heart Valve Diseases Regurgitation (circulation) Aortic valve repair Bicuspid aortic valve Bicuspid Aortic Valve Disease medicine Endocarditis Humans Stroke Retrospective Studies business.industry Incidence (epidemiology) Middle Aged medicine.disease Surgery medicine.anatomical_structure Treatment Outcome Aortic Valve Cardiology and Cardiovascular Medicine business |
Zdroj: | Journal of cardiac surgeryREFERENCES. 36(12) |
ISSN: | 1540-8191 |
Popis: | Background The aim of this study was to evaluate the longer-term results of bicuspid aortic valve (BAV) repair with or without aortic root replacement. Methods From 1999 to 2017, 142 patients with or without aortic root dilatation who underwent repair of a regurgitant BAV were included in the study. Ninety-four patients underwent isolated BAV repair (Group 1; median age 43 years) and 48 patients underwent valve-sparing aortic root replacement plus BAV repair (aortic valve reimplantation-Group 2; median age 48 years). Median clinical follow-up time was 5.9 years (range 0.5-15) in Group 1 and 3 years (range 0.5-16) in Group 2, respectively. Results In-hospital mortality was 1% in Group 1, and 2% in Group 2 (p = .6). The 5- and 10-year survival was 93 ± 2.9% and 81 ± 5.8% in Group 1 and 96 ± 3.1% and 96 ± 3.1% in Group 2, respectively (p = .31). Eleven patients of Group 1 (1.7%/patient-year) and five patients of Group 2 (2.2%/patient-year) underwent reoperation of the aortic valve (p = .5). The 5- and 10-year freedom from reoperation were 93.0 ± 2.1% and 77.1 ± 7.1% in Group 1 and 93.0 ± 5.0% and 76.7 ± 9.6% in Group 2 (p = .83), respectively. At the latest follow-up, only two patients of Group 1 and 1 patient of Group 2 had AV regurgitation = 2° (p = .7). The cumulative linearized incidence of all valve-related complications (bleeding, stroke, endocarditis, and reoperation) was 2.9%/patient-year in Group 1% and 4%/patient-year in Group 2, respectively (p = .6). Conclusions Isolated BAV repair and combined aortic valve reimplantation plus BAV repair provide good clinical longer-term outcomes with relatively low reoperation rate and durable valve function. |
Databáze: | OpenAIRE |
Externí odkaz: |